Tectonic Therapeutic (TECX) Liabilities and Shareholders Equity (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $246.6 million in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 21.68% year-over-year to $246.6 million in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 30.06% increase from a year earlier, with the FY2025 full-year figure at $261.0 million, up 70.72% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $246.6 million, down from $261.0 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for TECX reached as high as $314.8 million in Q1 2025 and fell as low as $39.4 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $172.0 million across 5 years, with a median of $152.9 million in 2024.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 62.1% in 2023 and jumped 288.09% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $103.9 million in 2022, then tumbled by 62.1% to $39.4 million in 2023, then soared by 288.09% to $152.9 million in 2024, then soared by 70.72% to $261.0 million in 2025, then decreased by 5.54% to $246.6 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $246.6 million in Q1 2026, $261.0 million in Q4 2025, and $277.0 million in Q3 2025.